Search

everythinglearnresearchcommunity

for

Search:↓

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Estrogen therapy can reduce skin aging but has cancer risks.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Early balding men may have insulin resistance, but lifestyle changes can help.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

DA-9401 helps protect rat testis from finasteride damage.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Testosterone may both worsen and protect against COVID-19 effects in men.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

A new low-cost method can accurately detect PCOS early by measuring free testosterone levels.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

External factors like pollution, stress, and poor nutrition can negatively affect hair growth.